tiprankstipranks
Advertisement
Advertisement

RNAZ Stock Latest News

TransCode Therapeutics Shareholders Approve Key Capital Measures
Company AnnouncementsTransCode Therapeutics Shareholders Approve Key Capital Measures
1d ago
8K
RNAZ
TransCode Therapeutics Updates Preferred Stock Ownership Limits
PremiumCompany Announcements
TransCode Therapeutics Updates Preferred Stock Ownership Limits
4d ago
8K
RNAZ
TransCode Adjourns Annual Meeting Amid Nasdaq Listing Steps
PremiumCompany Announcements
TransCode Adjourns Annual Meeting Amid Nasdaq Listing Steps
19d ago
8K
RNAZ
TransCode Highlights Progress of Lead RNA Cancer Therapeutic
PremiumCompany Announcements
TransCode Highlights Progress of Lead RNA Cancer Therapeutic
1M ago
8K
RNAZ
Transcode reports results from Phase 1a dose escalation trial with TTX-MC138
PremiumThe Fly
Transcode reports results from Phase 1a dose escalation trial with TTX-MC138
2M ago
RNAZ
TransCode Therapeutics Advances TTX-MC138 After Positive Phase 1a
PremiumCompany AnnouncementsTransCode Therapeutics Advances TTX-MC138 After Positive Phase 1a
2M ago
8K
RNAZ
TransCode Sets Key Deadlines for 2026 Shareholder Meeting
Premium
Company Announcements
TransCode Sets Key Deadlines for 2026 Shareholder Meeting
2M ago
8K
RNAZ
Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138
Premium
The Fly
Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138
2M ago
RNAZ
TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice
PremiumCompany Announcements
TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice
2M ago
8K
RNAZ
Transcode Therapeutics files to sell 1.53M shares of common stock for holders
PremiumThe Fly
Transcode Therapeutics files to sell 1.53M shares of common stock for holders
3M ago
RNAZ
Transcode Therapeutics files to sell 15.96M shares of common stock for holders
PremiumThe Fly
Transcode Therapeutics files to sell 15.96M shares of common stock for holders
3M ago
RNAZ
Transcode Therapeutics appoints Anna Moore as Chair of Scientific Advisory
PremiumThe Fly
Transcode Therapeutics appoints Anna Moore as Chair of Scientific Advisory
3M ago
RNAZ
Transcode Therapeutics signs research agreement with Michigan State University
PremiumThe FlyTranscode Therapeutics signs research agreement with Michigan State University
3M ago
RNAZ
Transcode Therapeutics signs flexible financing agreement for up to $20M
Premium
The Fly
Transcode Therapeutics signs flexible financing agreement for up to $20M
4M ago
RNAZ
TransCode Therapeutics Secures New Financing to Extend Runway
Premium
Company Announcements
TransCode Therapeutics Secures New Financing to Extend Runway
4M ago
8K
RNAZ
TransCode Therapeutics Delays 2025 Annual Filing
PremiumCompany Announcements
TransCode Therapeutics Delays 2025 Annual Filing
4M ago
RNAZ
TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal
PremiumCompany Announcements
TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal
5M ago
8K
RNAZ
Transcode Therapeutics enters exclusive license agreement with Unleash
PremiumThe Fly
Transcode Therapeutics enters exclusive license agreement with Unleash
5M ago
RNAZ
TransCode Unveils Tumor-Selective RIG-I Agonist Imaging Strategy
PremiumCompany Announcements
TransCode Unveils Tumor-Selective RIG-I Agonist Imaging Strategy
5M ago
8K
RNAZ
TransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial
PremiumCompany AnnouncementsTransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial
6M ago
8K
RNAZ
Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138
Premium
The Fly
Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138
6M ago
RNAZ
TransCode Therapeutics reports promising preclinical glioblastoma results
Premium
Company Announcements
TransCode Therapeutics reports promising preclinical glioblastoma results
7M ago
8K
RNAZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >